|
1
|
|
|
2
|
- Measuring the mechanical properties of the developing clot:
- The time it takes until initial fibrin formation.
- The kinetics of the initial fibrin clot to reach maximum strength.
- The ultimate strength and stability of the fibrin clot, ie. its ability
to mechanically impede hemorrhage without permitting inappropriate
thrombosis.
|
|
3
|
- Since the TEG analyzer monitors the shear elasticity of clotting blood,
it is sensitive to all the interacting cellular and plasma components
such as coagulation and fibrinolytic factors, activators, and
inhibitors, that may effect the rate or structure of a clotting sample
and its breakdown.
|
|
4
|
- This presentation will be based on a widely-used TEG analyzer: TEG-5000
Thrombelastograph® Hemostasis Analyzer
(Haemoscope Co., Niles, IL )
|
|
5
|
|
|
6
|
- The TEG analyzer has a sample cup that oscillates back and forth
constantly at a set speed through an arc of 4°45'. Each rotation lasts
ten seconds. A whole blood sample of 360 ul is placed into the cup, and
a stationary pin attached to a torsion wire is immersed into the blood.
- When the first fibrin forms, it begins to bind the cup and pin, causing
the pin to oscillate in phase with the clot. The acceleration of the
movement of the pin is a function of the kinetics of clot development.
|
|
7
|
|
|
8
|
- The torque of the rotating cup is transmitted to the immersed pin only
after fibrin-platelet bonding has linked the cup and pin together. The
strength of these fibrin-platelet bonds moves the pin directly in phase
with the cup motion. Thus, the magnitude of the output is directly
related to the strength of the formed clot.
- As the clot retracts or lyses, these bonds are broken and the transfer
of cup motion is diminished. The rotation movement of the pin is
converted by a mechanical-electrical transducer to an electrical signal
which can be monitored by a computer.
|
|
9
|
- The resulting hemostasis profile is a measure of:
- -The time it takes for the
first fibrin strand to be formed,
-The kinetics of clot formation,
-The strength of the clot (in shear elasticity units of dyn/cm2),
and
-Dissolution of clot.
|
|
10
|
- Whole blood samples provide the most sensitive method for analysis.
However, most times it is not practical or necessary to run a straight
native sample. Samples can be citrated to prolong storage
time. Calcium Chloride is added
to the sample at testing time
- Testing sample may be native blood, or with added reagents. Added
reagents may include: kaolin, Aprotinin, heparinase. Appropriate
reference ranges are used for each type
|
|
11
|
|
|
12
|
|
|
13
|
- TEG is a global test for hemostasis that includes interaction of primary
and secondary hemostasis
- Subsequently, defect in one component of hemostasis can affect the other
to certain extense
- In reading TEG data/tracing, it is most important to focus on the most
significant defect
|
|
14
|
|
|
15
|
|
|
16
|
|
|
17
|
|
|
18
|
|
|
19
|
|
|
20
|
|
|
21
|
|
|
22
|
|
|
23
|
|
|
24
|
|
|
25
|
|
|
26
|
- R-time: 3.0-8.0 min
- K-time: 1.0-4.0 min
- Angle: 55.0-78.0 degree
- Max Amp: 51.0-69.0 mm
- G-value: 4.6-10.9 103 d/sc
- Ly30: 0.0-7.5 %
- Coag Index: -3.0 to +3.0
- Normal ranges are for citrated whole blood with kaolin activator.
|
|
27
|
|
|
28
|
- N: in ref range
- N/+: in or slightly above ref range
- N/-: in or slightly below ref range
- ++: marked increase above ref range
- --: marked decrease below ref range
|
|
29
|
- Abbreviated TEG for rapid turn-around-time (trauma setting)
- Whole blood obtained in syrynge without anticoagulant, to be tested
within 4 minutes after drawing
- No measurement of LY30
- Addition of activated clotting time (ACT) to better assess clotting
factors (R is very short and less accurate)
|
|
30
|
- ACT: 76-110 sec
- R-time: 0.3-0.6 min
- K-time: 0.5-2.0 min
- Angle: 66.3-81.9 degree
- Max Amp: 54.1-72.5 mm
- G-value: 5.3-12.4 103 d/sc
- Normal ranges are for non-anticoagulated whole blood
|